Site içinde arama yapın

Tomas Gil bir ses eklendi Other
2026-05-11 13:15:14 -

India Clinical Trials Market Size, Share, Trends and Forecast 2026-2035
As per the latest research by Expert Market Research, the India Clinical Trials Market in 2025 is valued at 1.66 USD Billion and is projected to expand at a CAGR of 7.1% during 2026–2035, reaching 3.3 USD Billion by 2035. The India Clinical Trials Market is witnessing significant expansion due to rising global outsourcing and regulatory improvements in the country. More details are...

0 Yorumlar 0 hisse senetleri 847 Views 0 önizleme

Please log in to like, share and comment!
Tomas Gil bir ses eklendi Other
2026-05-11 13:15:49 -

India Clinical Trials Market Size, Share, Trends and Forecast 2026-2035
As per the latest research by Expert Market Research, the India Clinical Trials Market in 2025 is valued at 1.66 USD Billion and is projected to expand at a CAGR of 7.1% during 2026–2035, reaching 3.3 USD Billion by 2035. The India Clinical Trials Market is witnessing significant expansion due to rising global outsourcing and regulatory improvements in the country. More details are...

0 Yorumlar 0 hisse senetleri 764 Views 0 önizleme

Please log in to like, share and comment!
Rutuja Deshmukh bir ses eklendi Other
2026-07-02 07:39:33 -

Pharmaceutical CRO Market Competitive Analysis and Key Players
The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...

0 Yorumlar 0 hisse senetleri 30 Views 0 önizleme

Please log in to like, share and comment!
Subhayan Mayra bir ses eklendi Other
2026-05-26 12:44:21 -

AI Clinical Trial Market Growing at 15% CAGR Through 2034
According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...

0 Yorumlar 0 hisse senetleri 954 Views 0 önizleme

Please log in to like, share and comment!